Evidence map›Paper›PMID 31022926›Full record

ArticleCancers2019

Histopathological Imaging⁻Environment Interactions in Cancer Modeling.

Yaqing Xu, Tingyan Zhong, Mengyun Wu, Shuangge Ma

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Machine-learning models based on histological images from healthy donors identify imageQTLs and predict chronological age.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yaqing XuDepartment of Biostatistics, Yale University, New Haven, CT 06520, USA. yaqing.xu@yale.edu.
Tingyan ZhongSJTU-Yale Joint Center for Biostatistics, Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China. tyzhong@sjtu.edu.cn.
Mengyun WuSchool of Statistics and Management, Shanghai University of Finance and Economics, Shanghai 200433, China. wu.mengyun@mail.shufe.edu.cn.
Shuangge MaDepartment of Biostatistics, Yale University, New Haven, CT 06520, USA. shuangge.ma@yale.edu.ORCID 0000-0001-9001-4999

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Harriet M. Kluger · 2015 to 2026
$31.1M
Novel methods for identifying genetic interactions in cancer prognosisR01CA204120 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2016 to 2026
$3.5M
National Bureau of Statistics of China 2018LD02National Natural Science Foundation of China 91546202, 71331006NCATS NIH HHS UL1 TR001863NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA204120NIH HHS CA204120, CA196530
6 · The paper itself

Abstract

Histopathological imaging has been routinely conducted in cancer diagnosis and recently used for modeling other cancer outcomes/phenotypes such as prognosis. Clinical/environmental factors have long been extensively used in cancer modeling. However, there is still a lack of study exploring possible interactions of histopathological imaging features and clinical/environmental risk factors in cancer modeling. In this article, we explore such a possibility and conduct both marginal and joint interaction analysis. Novel statistical methods, which are "borrowed" from gene⁻environment interaction analysis, are employed. Analysis of The Cancer Genome Atlas (TCGA) lung adenocarcinoma (LUAD) data is conducted. More specifically, we examine a biomarker of lung function as well as overall survival. Possible interaction effects are identified. Overall, this study can suggest an alternative way of cancer modeling that innovatively combines histopathological imaging and clinical/environmental data.

Indexed as

cancer modelingclinical/environmental factorshistopathological imaginginteraction

Identifiers

PMID31022926
PMCPMC6520737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.